Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions
2 months ago
People
R&D
SpringWorks lands FDA approval for nerve tumor treatment
2 months ago
R&D
FDA+
Travere plans to seek expanded label for kidney drug despite failed trial
2 months ago
FDA+
Biohaven lands priority review on second-chance application for neurodegenerative drug
2 months ago
FDA+
What will pharma's share buyback shopping spree mean for M&A?
2 months ago
Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos
2 months ago
Deals
Vertex operations chief Stuart Arbuckle to retire
2 months ago
People
Updated: Judge halts NIH cuts nationwide after groups, 22 states sue
2 months ago
Law
Merck KGaA confirms interest in acquiring cancer biotech SpringWorks
2 months ago
R&D
Eli Lilly inks $630M deal for Phase 1 MASH candidate
2 months ago
Deals
Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners
2 months ago
China
Manufacturing
Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisk
2 months ago
Health Tech
Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma
2 months ago
Deals
AbbVie wins FDA approval for new antibiotic to treat complex intra-abdominal infections
3 months ago
FDA+
Sanofi, AstraZeneca back Teva's call to rehear case on patent listings
3 months ago
Law
Belgian regulator recommends blocking Indian drugmaker's API production
3 months ago
Manufacturing
Bristol Myers prunes pipeline amid new round of cost cuts
3 months ago
Updated: Hospital group blasts proposed 340B rebate models, requests to join lawsuits with HHS
3 months ago
Law
AstraZeneca takes $753M charge on abandoned complement drug from Alexion deal
3 months ago
J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker
3 months ago
Deals
Pfizer hires Novartis oncology exec to steer its cancer ambitions
3 months ago
People
AstraZeneca offers some detail on China probe, reaffirms commitment to that market
3 months ago
China
Law
Updated: Lilly posts 45% sales jump, culls four programs across obesity, Alzheimer's, heart failure and eczema
3 months ago
Bristol Myers launches fresh round of major cost cuts in bid to get ahead of patent cliff
3 months ago
First page
Previous page
11
12
13
14
15
16
17
Next page
Last page